Sandu Pharmaceuticals Balance Sheet Annual

BSE: 524703 | NSE: - | ISIN: INE751D01014 | Sector: Biotechnology & Drugs

37.27 +0.74 (2.03%)Updated : 05 Oct 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Liabilities Shareholders' Equity	55.87	55.72	52.41	54.17
Cash Equivalents	5.91	1.30	1.00	2.28
Other Liabilities Total	0.00	-	-	-
Common Stock Total	9.66	9.66	9.66	9.66
Other Current Assets Total	2.58	4.74	3.98	4.13
Total Assets	55.87	55.72	52.41	54.17
Current Portof LT Debt/ Capital Leases	0.11	0.06	0.00	-
Total Equity	43.67	42.02	40.59	39.24
Long Term Investments	12.33	11.27	12.23	11.58
Retained Earnings( Accumulated Deficit)	34.01	32.36	30.93	29.58
Total Common Shares Outstanding	0.97	0.97	0.97	0.97
Tangible Book Valueper Share Common Eq	45.19	43.47	41.98	40.57
Total Liabilities	12.20	13.70	11.82	14.93
Total Debt	0.42	0.48	0.06	0.00
Short Term Investments	0.95	1.35	0.20	0.02
Cashand Short Term Investments	6.86	2.65	1.21	2.30
Total Receivables Net	5.41	4.76	4.87	4.79
Notes Payable/ Short Term Debt	0.00	0.00	0.00	0.00
Deferred Income Tax	1.46	1.20	1.12	1.04
Accounts Receivable- Trade Net	5.41	4.76	4.87	4.79
Property/ Plant/ Equipment Total- Net	18.17	18.12	17.84	16.99
Total Current Liabilities	10.42	12.09	10.64	13.88
Total Inventory	10.47	14.15	12.25	14.33
Accounts Payable	4.47	4.49	4.20	8.40
Other Currentliabilities Total	5.84	7.54	6.44	5.49
Total Long Term Debt	0.31	0.42	0.06	0.00
Intangibles Net	0.02	0.02	0.03	0.05
Other Long Term Assets Total	0.03	0.00	0.00	0.00
period Length	0.00	0.00	0.00	0.00
Total Current Assets	25.32	26.30	22.30	25.54
Capital Lease Obligations	0.31	0.42	0.06	-
Other Equity Total	-	-	-	0.00